vs

Side-by-side financial comparison of CONSUMER PORTFOLIO SERVICES, INC. (CPSS) and Kiniksa Pharmaceuticals International, plc (KNSA). Click either name above to swap in a different company.

Kiniksa Pharmaceuticals International, plc is the larger business by last-quarter revenue ($202.1M vs $109.4M, roughly 1.8× CONSUMER PORTFOLIO SERVICES, INC.). Kiniksa Pharmaceuticals International, plc runs the higher net margin — 7.0% vs 4.6%, a 2.5% gap on every dollar of revenue. On growth, Kiniksa Pharmaceuticals International, plc posted the faster year-over-year revenue change (65.0% vs 3.9%). CONSUMER PORTFOLIO SERVICES, INC. produced more free cash flow last quarter ($288.3M vs $53.3M). Over the past eight quarters, Kiniksa Pharmaceuticals International, plc's revenue compounded faster (59.1% CAGR vs 9.2%).

Consumer Portfolio Services, Inc. is a U.S. specialty finance firm providing indirect auto loan financing and servicing for consumers with limited or subprime credit. It partners with franchised and independent car dealerships nationwide to originate installment contracts for new and used vehicle purchases.

Kiniksa Pharmaceuticals International plc is a global biopharmaceutical firm focused on discovering, developing and commercializing targeted therapies for patients with unmet medical needs, primarily in autoimmune, inflammatory and rare disease segments. It operates across major markets including North America, Europe and Asia, advancing a pipeline of clinical-stage and approved treatment candidates.

CPSS vs KNSA — Head-to-Head

Bigger by revenue
KNSA
KNSA
1.8× larger
KNSA
$202.1M
$109.4M
CPSS
Growing faster (revenue YoY)
KNSA
KNSA
+61.1% gap
KNSA
65.0%
3.9%
CPSS
Higher net margin
KNSA
KNSA
2.5% more per $
KNSA
7.0%
4.6%
CPSS
More free cash flow
CPSS
CPSS
$235.0M more FCF
CPSS
$288.3M
$53.3M
KNSA
Faster 2-yr revenue CAGR
KNSA
KNSA
Annualised
KNSA
59.1%
9.2%
CPSS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPSS
CPSS
KNSA
KNSA
Revenue
$109.4M
$202.1M
Net Profit
$5.0M
$14.2M
Gross Margin
89.6%
Operating Margin
6.6%
9.8%
Net Margin
4.6%
7.0%
Revenue YoY
3.9%
65.0%
Net Profit YoY
-3.2%
259.8%
EPS (diluted)
$0.21
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPSS
CPSS
KNSA
KNSA
Q4 25
$109.4M
$202.1M
Q3 25
$108.4M
$180.9M
Q2 25
$109.8M
$156.8M
Q1 25
$106.9M
$137.8M
Q4 24
$105.3M
$122.5M
Q3 24
$100.6M
$112.2M
Q2 24
$95.9M
$108.6M
Q1 24
$91.7M
$79.9M
Net Profit
CPSS
CPSS
KNSA
KNSA
Q4 25
$5.0M
$14.2M
Q3 25
$4.9M
$18.4M
Q2 25
$4.8M
$17.8M
Q1 25
$4.7M
$8.5M
Q4 24
$5.1M
$-8.9M
Q3 24
$4.8M
$-12.7M
Q2 24
$4.7M
$-3.9M
Q1 24
$4.6M
$-17.7M
Gross Margin
CPSS
CPSS
KNSA
KNSA
Q4 25
89.6%
Q3 25
88.8%
Q2 25
88.1%
Q1 25
87.0%
Q4 24
85.4%
Q3 24
82.1%
Q2 24
88.7%
Q1 24
86.7%
Operating Margin
CPSS
CPSS
KNSA
KNSA
Q4 25
6.6%
9.8%
Q3 25
6.5%
13.3%
Q2 25
6.3%
12.9%
Q1 25
6.4%
9.6%
Q4 24
7.0%
-15.7%
Q3 24
6.8%
-8.6%
Q2 24
7.0%
-0.1%
Q1 24
7.1%
-20.7%
Net Margin
CPSS
CPSS
KNSA
KNSA
Q4 25
4.6%
7.0%
Q3 25
4.5%
10.2%
Q2 25
4.4%
11.4%
Q1 25
4.4%
6.2%
Q4 24
4.9%
-7.3%
Q3 24
4.8%
-11.3%
Q2 24
4.9%
-3.6%
Q1 24
5.0%
-22.2%
EPS (diluted)
CPSS
CPSS
KNSA
KNSA
Q4 25
$0.21
$0.18
Q3 25
$0.20
$0.23
Q2 25
$0.20
$0.23
Q1 25
$0.19
$0.11
Q4 24
$0.21
$-0.11
Q3 24
$0.20
$-0.18
Q2 24
$0.19
$-0.06
Q1 24
$0.19
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPSS
CPSS
KNSA
KNSA
Cash + ST InvestmentsLiquidity on hand
$6.3M
$414.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$309.5M
$567.6M
Total Assets
$3.9B
$763.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPSS
CPSS
KNSA
KNSA
Q4 25
$6.3M
$414.1M
Q3 25
$9.4M
$352.1M
Q2 25
$15.8M
$307.8M
Q1 25
$29.8M
$268.3M
Q4 24
$11.7M
$243.6M
Q3 24
$8.1M
$223.8M
Q2 24
$9.8M
$218.8M
Q1 24
$13.2M
$213.6M
Stockholders' Equity
CPSS
CPSS
KNSA
KNSA
Q4 25
$309.5M
$567.6M
Q3 25
$307.6M
$535.4M
Q2 25
$303.1M
$495.0M
Q1 25
$298.4M
$457.5M
Q4 24
$292.8M
$438.4M
Q3 24
$285.1M
$437.0M
Q2 24
$280.3M
$435.1M
Q1 24
$279.1M
$431.9M
Total Assets
CPSS
CPSS
KNSA
KNSA
Q4 25
$3.9B
$763.6M
Q3 25
$3.8B
$712.3M
Q2 25
$3.8B
$661.1M
Q1 25
$3.7B
$599.3M
Q4 24
$3.5B
$580.6M
Q3 24
$3.5B
$555.3M
Q2 24
$3.3B
$542.4M
Q1 24
$3.0B
$519.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPSS
CPSS
KNSA
KNSA
Operating Cash FlowLast quarter
$289.0M
$53.9M
Free Cash FlowOCF − Capex
$288.3M
$53.3M
FCF MarginFCF / Revenue
263.5%
26.4%
Capex IntensityCapex / Revenue
0.6%
0.3%
Cash ConversionOCF / Net Profit
58.02×
3.80×
TTM Free Cash FlowTrailing 4 quarters
$500.9M
$136.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPSS
CPSS
KNSA
KNSA
Q4 25
$289.0M
$53.9M
Q3 25
$84.9M
$33.7M
Q2 25
$54.5M
$28.1M
Q1 25
$73.9M
$22.3M
Q4 24
$233.8M
$18.8M
Q3 24
$69.8M
$-2.2M
Q2 24
$43.3M
$5.2M
Q1 24
$52.7M
$4.0M
Free Cash Flow
CPSS
CPSS
KNSA
KNSA
Q4 25
$288.3M
$53.3M
Q3 25
$84.9M
$33.0M
Q2 25
$54.3M
$27.9M
Q1 25
$73.4M
$22.2M
Q4 24
$233.3M
$18.6M
Q3 24
$69.7M
Q2 24
$43.1M
Q1 24
$52.6M
$3.9M
FCF Margin
CPSS
CPSS
KNSA
KNSA
Q4 25
263.5%
26.4%
Q3 25
78.3%
18.2%
Q2 25
49.5%
17.8%
Q1 25
68.7%
16.1%
Q4 24
221.6%
15.2%
Q3 24
69.3%
Q2 24
45.0%
Q1 24
57.3%
4.9%
Capex Intensity
CPSS
CPSS
KNSA
KNSA
Q4 25
0.6%
0.3%
Q3 25
0.0%
0.4%
Q2 25
0.1%
0.1%
Q1 25
0.4%
0.1%
Q4 24
0.4%
0.2%
Q3 24
0.1%
0.0%
Q2 24
0.2%
0.0%
Q1 24
0.1%
0.1%
Cash Conversion
CPSS
CPSS
KNSA
KNSA
Q4 25
58.02×
3.80×
Q3 25
17.50×
1.83×
Q2 25
11.35×
1.58×
Q1 25
15.74×
2.61×
Q4 24
45.43×
Q3 24
14.55×
Q2 24
9.27×
Q1 24
11.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons